secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-09-17T13:27:26+00:00
Accession:  0001140361-26-036866
Event type: m_and_a
Sentiment:  negative
Materiality: 0.95
Item codes: 1.01, 5.03, 2.01, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata closes Marea reverse merger; $225M PIPE financing
--------------------------------------------------------

- Merger closed Sept 17, 2026; Marea stockholders get 1,793,129 LSTA shares + 211,365 Series C preferred (convertible to common).
- $225M PIPE: 150,867.995 Series C preferred shares sold to investors; expected close Sept 18, 2026.
- Post-deal ownership: LSTA legacy holders ~2.39%, Marea holders ~59.54%, PIPE investors ~38.07% (on conversion).
- Ted Love (ex-GBT CEO) joins board; Josh Lehrer (Marea CEO) named President & COO; Mazzo stays CEO.
- 180-day lock-up on insider shares; stockholder vote needed for Series C conversion and change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126036866/0001140361-26-036866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126036866/ef20082158_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-036866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer